| Structure | Chemical Name | CAS | MF |
|
3-(4-NITROPHENOXY)-2-THIOPHENECARBOXYLIC ACID
|
252026-66-7
|
C11H7NO5S
|
|
3-(2-NITROPHENOXY)-2-THIOPHENECARBOXYLIC ACID
|
252026-99-6
|
C11H7NO5S
|
|
1,4-Piperidinedicarboxylicacid,4-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-,1-(9H-fluoren-9-ylmethyl)ester(9CI)
|
252029-00-8
|
C36H32N2O6
|
|
TAUROCHOLIC ACID-D4
|
252030-90-3
|
C26H45NO7S
|
|
Fatty acids, C18-unsatd., dimers, di-Me esters, hydrogenated polymers with adipic acid, 5-amino-1,3,3-trimethylcyclohexanemethanamine, 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane and 3-methyl-1,5-pentanediol
|
252046-77-8
|
|
|
|
Alkylene(C=36) diamines polymers with adipic acid, 5-amino-1,3,3-trimethylcyclohexanemethanamine, 5-isocyanato-1-(isocyanatomethyl)-1,3,3- trimethylcyclohexane, 3-methyl-1,5-pentanediol and propylene glycol
|
252046-82-5
|
|
|
Fmoc-D-Threoninol
|
252049-02-8
|
C19H21NO4
|
|
FMOC-L-ALLO-THREONINOL
|
252049-03-9
|
C19H21NO4
|
|
FMOC-ORN(DNP)-OH
|
252049-04-0
|
C26H24N4O8
|
|
FMOC-MENVA-OH
|
252049-05-1
|
C21H23NO4
|
|
FMOC-N-ME-THR-OH
|
252049-06-2
|
C20H21NO5
|
|
FMOC-DAB(Z)-OH
|
252049-08-4
|
C27H26N2O6
|
|
FMOC-LYS(ME)2-OH HCL
|
252049-10-8
|
C23H29ClN2O4
|
|
Fmoc-Lys(nicotinoyl)-OH
|
252049-11-9
|
C27H27N3O5
|
|
FMOC-D-LYS(NICOTINOYL)-OH
|
252049-12-0
|
C27H27N3O5
|
|
FMOC-BETA-(2,2-DIMETHYL-4H-BENZO[1,3]-DIOXIN-6-YL)-ALA-OH
|
252049-13-1
|
C28H27NO6
|
|
FMOC-D-4-TERT-BUTYL-PHE
|
252049-14-2
|
C28H29NO4
|
|
FMOC-HIS(3-ME)-OH
|
252049-16-4
|
C22H21N3O4
|
|
FMOC-D-GLU-OFM
|
252049-17-5
|
C34H29NO6
|
|
FMOC-D-CYS(BZL)-OH
|
252049-18-6
|
C25H23NO4S
|
|
2-Furanmethanamine, 5-(1H-imidazol-4-yl)- (9CI)
|
252054-00-5
|
C8H9N3O
|
|
1-(TRIMETHYLSILYL)-2-NAPHTHYL TRIFLATE
|
252054-88-9
|
C14H15F3O3SSi
|
|
Ethanone, 2,2,2-trifluoro-1-[2-(hydroxymethylamino)-1-cyclopenten-1-yl]- (9CI)
|
252055-20-2
|
C8H10F3NO2
|
|
5-Amino-3-methylpyridine-2-carbonitrile
|
252056-70-5
|
C7H7N3
|
|
2-(METHYLSULFANYL)-6-PHENYLNICOTINONITRILE
|
252058-91-6
|
C13H10N2S
|
|
6-(4-CHLOROPHENYL)-2-(METHYLSULFANYL)NICOTINONITRILE
|
252059-07-7
|
C13H9ClN2S
|
|
6-(4-FLUOROPHENYL)-2-(METHYLSULFANYL)NICOTINONITRILE
|
252059-95-3
|
C13H9FN2S
|
|
1H-Isoindol-1-one, 2,3-dihydro-5-hydroxy- (9CI)
|
252061-66-8
|
C8H7NO2
|
|
6-hydroxyisoquinolin-1(2H)-one
|
252061-78-2
|
C9H7NO2
|
|
1,4-DIHYDRO-6-PHENYLMETHOXY-3(2H)-ISOQUINOLINONE
|
252061-87-3
|
C16H15NO2
|
|
7-(benzyloxy)-1,2,3,4-tetrahydroisoquinoline
|
252061-94-2
|
C16H17NO
|
|
1,3-DIVINYL-1,1,3,3-TETRAMETHYLDISILOXANEPALLADIUM(0)
|
252062-59-2
|
C24H42O3Pd2Si6
|
|
(3S,4aS,8aS)-2-[(2R,3R)-3-[(3-Amino-2-hydroxy-4-phenythiobutyl]-decahydro-N-(2-hydroxy-1,1-dimethylethyl)-3-isoquinolinecarboxamide
|
252186-41-7
|
C24H39N3O3S
|
|
5-DesaMino 5-Oxo-2,5-dihydro LaMotrigine
|
252186-78-0
|
C9H6Cl2N4O
|
|
3-(2,3-DichlorobenzaMido) LaMotrigine
|
252186-79-1
|
C16H9Cl4N5O
|
|
Ceftobiprole Medocaril Sodium Sterile Powder
|
252188-71-9
|
C26H27N8NaO11S2
|
|
1,8-diaMino-4,5-dihydroxyanthracene-9,10-dione
|
252189-08-5
|
C14H10N2O4
|
|
Hydroxy-ε-sanshool
|
252193-26-3
|
C16H25NO2
|
|
1-PROPANONE, 1-(4-CHLOROPHENYL)-2-[(1,1-DIMETHYLETHYL)AMINO]- (9CL)
|
252193-58-1
|
C13H18ClNO
|
|
TERTIAPIN-Q
|
252198-49-5
|
C100H163N31O23S4
|
|
4-(3,4-DICHLOROPHENYL)-5-(4-PYRIDINYL)-2-THIAZOLAMINE
|
252198-68-8
|
C14H9Cl2N3S
|
|
4-(BENZYLOXY)-N-METHOXY-N-METHYLBENZAMIDE
|
252199-28-3
|
C16H17NO3
|
|
(2R,3S)-3-(FMOC-AMINO)-2-HYDROXY-3-PHENYL-PROPANOIC ACID
|
252206-27-2
|
C24H21NO5
|
|
4-(FMOC-AMINO)-1-METHYL-1H-IMIDAZOLE-2-CARBOXYLIC ACID
|
252206-28-3
|
C20H17N3O4
|
|
Fmoc-D-Cys(Mtt)-OH
|
252206-29-4
|
C38H33NO4S
|
|
methyl 2-(3-aminophenyl)-2-methylpropanoate
|
252209-96-4
|
C11H15NO2
|
|
DiMethyl 5-ChloroMethyl-1,3-Benzene-Dicarboxylate
|
252210-01-8
|
C11H11ClO4
|
|
4-chloro-5-ethoxypyridazin-3(2H)-one
|
252210-37-0
|
C6H7ClN2O2
|
|
1,2-Benzenediol,4-[1-methyl-2-[(1-methylethyl)amino]ethyl]-(9CI)
|
252212-81-0
|
C12H19NO2
|
|
Boroxin, tris[(triphenylstannyl)oxy]- (9CI)
|
252228-35-6
|
C54H45B3O6Sn3
|
|
Boroxin, tris[(trimethylstannyl)oxy]- (9CI)
|
252228-36-7
|
C9H27B3O6Sn3
|
|
2(1H)-Pyrazinone,6-amino-5-methyl-(9CI)
|
252230-09-4
|
C5H7N3O
|
|
Imidazo[1,2-c]pyrimidin-5(1H)-one, 7-amino- (9CI)
|
252230-10-7
|
C6H6N4O
|
|
2(1H)-Pyrazinone,6-amino-3-methyl-(9CI)
|
252230-11-8
|
C5H7N3O
|
|
Butyltriphenylphosphonium fluoride
|
252234-71-2
|
C22H24FP
|
|
(3,3,4,4,5,5,6,6,7,7,8,8,8-Tridecafluorooct-1-yl)phosphonic acid
|
252237-40-4
|
C8H6F13O3P
|
|
1-CinnaMoylpyrrole
|
252248-89-8
|
C13H11NO
|
|
Benzamide, 3-(hydroxyamino)- (9CI)
|
252251-19-7
|
C7H8N2O2
|
|
Z-GLU-LEU-OH
|
252253-22-8
|
C19H26N2O7
|
|
2-(2-phenylpropan-2-yl)-1,3,4-oxadiazole
|
252253-32-0
|
C11H12N2O
|
|
(4S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoroMethyl)-2H-3,1-
benzoxazine
|
252253-57-9
|
C14H11ClF3NO
|
|
CYANINE 5 BIHEXANOIC ACID DYE, POTASSIUM SALT
|
252255-40-6
|
C37H45KN2O10S2
|
|
CYANINE 5 BIHEXANOIC ACID DYE, SUCCINIMIDYL ESTER, POTASSIUM SALT
|
252255-42-8
|
C45H51KN4O14S2
|
|
AMYLOID BETA/A4 PROTEIN PRECURSOR770 (667-676)
|
252256-37-4
|
C51H82N14O18S
|
|
(VAL671)-AMYLOID BETA/A4 PROTEIN PRECURSOR770 (667-676)
|
252256-43-2
|
C51H82N14O18
|
|
posizolid
|
252260-02-9
|
C21H21F2N3O7
|
|
Ethyl 1-(6-Chloropyridazin-3-yl)piperidine-4-carboxylate
|
252263-47-1
|
C12H16ClN3O2
|
|
3-(Boc-aMinoethyloxy)benzonitrile
|
252263-98-2
|
C14H18N2O3
|
|
5-Hexen-2-one, 3-hydroxy-, (3S)- (9CI)
|
252265-28-4
|
C6H10O2
|
|
DICHLOROBORANE-DIOXANE COMPLEX 3M SOLU&
|
252265-33-1
|
C4H9BCl2O2
|
|
Ethanol, 2-[(6-methyl-3-pyridinyl)oxy]- (9CI)
|
252266-86-7
|
C8H11NO2
|
|
4-(morpholine-4-carbonyl)-9H-fluoren-9-one
|
252280-76-5
|
C18H15NO3
|
|
(S)-(+)-(3,5-Dioxa-4-phospha-cyclohepta[2,1-a
|
252288-04-3
|
C24H22NO2P
|
|
Furo[3,4-b]pyridin-5(7H)-one, 7-hydroxy- (9CI)
|
252289-75-1
|
C7H5NO3
|
|
7-Azabicyclo[2.2.1]heptane,2-(5-isoxazolyl)-,(1R,2S,4S)-rel-(9CI)
|
252305-03-6
|
C9H12N2O
|
|
1H-Pyrazole-1-propanenitrile, 2,3-dihydro-5-methyl-3-oxo- (9CI)
|
252308-56-8
|
C7H9N3O
|
|
|
Magnesium, carbonate fumarate hydroxy mono-C10-13-alkylbenzenesulfonate monopolybutenylbenzenesulfonate complexes
|
252312-98-4
|
|
|
|
Calcium, carbonate monopolybutenylbenzenesulfonate succinate complexes
|
252315-85-8
|
|
|
{(3S)-1-[1-(2,3-DIHYDRO-1-BENZOFURAN-5-YL)ETHYL]PYRROLIDIN-3-YL}DIPHENYLACETONITRILE
|
252317-48-9
|
C28H28N2O
|
|
2,5-Cyclohexadiene-1-methanol,4-(1-methylethyl)-(9CI)
|
252326-85-5
|
C10H16O
|
|
(R)-5-(hydroxymethyl)-3-(4-iodophenyl)oxazolidin-2-one
|
252330-13-5
|
C10H10INO3
|
|
1-(6-broMo-3,4-dihydro-2(1H)-isoquinolinyl)-2,2,2-trifluoro-Ethanone
|
252331-63-8
|
C11H9BrF3NO
|
|
Ethanone, 1-(3-hydroxybicyclo[2.2.1]hept-2-yl)- (9CI)
|
252332-94-8
|
C9H14O2
|
|
9,9'-O-isopropyllidene-isolariciresil
|
252333-71-4
|
C23H28O6
|
|
Isotaxiresinol 9,9'-acetonide
|
252333-72-5
|
C22H26O6
|
|
Z-ALA-ALA-LYS-OH
|
252336-23-5
|
C20H30N4O6
|
|
8-(2-FLUORO-4-NITROPHENYL)-1,4-DIOXA-8-AZASPIRO[4.5]DECANE
|
252336-82-6
|
C13H15FN2O4
|
|
5-[N-(6-(TRIFLUOROACETAMIDO)HEXYL)-3(E)-ACRYLAMIDO]-2'-DEOXYURIDINE
|
252337-58-9
|
C20H27F3N4O7
|
|
(5'-O-(DIMETHOXYTRITYL)-5-[N-(6-(TRIFLUOROACETAMIDO)HEXYL)-3-(E)-ACRYLAMIDO]-2'-DEOXYURIDINE)
|
252337-59-0
|
C41H45F3N4O9
|
|
5-[N-(6-AMINOHEXYL)-3-(E)-ACRYLAMIDO]-5'-O-(DIMETHOXYTRITYL)-2'-DEOXYURIDINE
|
252337-60-3
|
C39H46N4O8
|
|
3-Fluoro-4-(4-methyl-1H-imidazol-1-yl)benzenamine
|
252340-70-8
|
C10H10FN3
|
|
N-TERT-BUTOXYCARBONYL-2-AMINOMETHYL-IMIDAZOLE-4-CARBOXYLIC ACID METHYL ESTER
|
252348-76-8
|
C11H17N3O4
|
|
1H-Benzimidazole-2-acetamide,alpha-cyano-(9CI)
|
252350-71-3
|
C10H8N4O
|
|
Z-PHE-GLY-PHE-GLY-OH
|
252351-91-0
|
C30H32N4O7
|
|
Z-D-GLU-TYR-OH
|
252351-92-1
|
C22H24N2O8
|
|
Lucidadiol
|
252351-95-4
|
C30H48O3
|
|
Lucidal
|
252351-96-5
|
C30H46O3
|
|
2-(1,3-BENZOXAZOL-2-YLTHIO)PROPANOIC ACID
|
252353-18-7
|
C10H9NO3S
|
|
6-FLUORO-2-METHYL-3-(4-PIPERIDINE)-1H-INDOLE
|
252354-45-3
|
C47H45F2N7O2
|
|
3-(5-ETHOXYCARBONYL-2-FURANYL)-1-PROPENE
|
252357-14-5
|
C10H12O3
|